Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
2023 · Nature Communications · 111 citations
https://doi.org/10.1038/s41467-023-37874-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
806
Citations
10
h-index
10
i10-index
Nikhil Kamat is an academic researcher from University of Washington. The author has contributed to research in topics: Cardiac Imaging and Diagnostics & Sodium Intake and Health & Immunotherapy and Immune Responses. The author has an h-index of 10, co-authored 35 publications.
ORCID: 0000-0001-9953-5053Click to start Chat